TLR3 and Alzheimer disease: These observations led us to investigate the plasma level of miR‐628‐3p, a potential TLR3 regulator, in AD patients with severe AKC with giant papillae and/or shield ulcers, in AD patients without AKC or with very mild AKC without giant papillae nor shield ulcers, and in healthy controls.